Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Klebsiella pneumoniae O-antigen polysaccharide is a structurally variable but functionally critical molecule that contributes significantly to bacterial survival during infection. It is a key component of the lipopolysaccharide (LPS) layer found on the outer membrane of Klebsiella pneumoniae. Its conserved features among dominant clinical isolates make it an important focus for diagnostics, therapeutics and vaccine design efforts aimed at combating multidrug-resistant K. pneumoniae. It protects against host immune responses, including complement-mediated killing and phagocytosis. There are several serotypes based on structural variations in these polysaccharides, with the most common clinically relevant serotypes being O1, O2, O3, and O5.
Antibodies targeting the O-antigen can mediate opsonophagocytic activity, agglutination, complement activation via classical pathway, and direct bactericidal effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Klebsiella pneumoniae O-antigen Polysaccharide (O-antigen).